Plus Therapeutics to trade on Nasdaq as Cerenome under CNSY ticker from Aug. 3

• Plus Therapeutics will complete its rebrand to Cerenome on Aug. 3, 2026.
• Nasdaq Capital Market trading will switch to ticker CNSY at the market open on Aug. 3.
• Stock listing status remains unchanged; the change does not alter shareholders’ ownership interests.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Plus Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607310830PRIMZONEFULLFEED9801613) on July 31, 2026, and is solely responsible for the information contained therein.